Spore-ing change: Rua Bioscience psilocybin study targets meth addiction

Spore-ing change: Rua Bioscience psilocybin study targets meth addiction
Gisborne-based pharmaceutical company Rua Bioscience is hoping mushrooms can help cure meth addiction. (Image: Supplied)
Gregor Thompson
Rua Bioscience is exploring psilocybin-containing mushrooms’ potential in treating methamphetamine addiction.The clinical study, dubbed Tū Wairua (standing with strength and spiritual connectedness), intends to combine historic Māori practices with modern science to tackle meth addiction.The New Zealand Exchange-listed (NZX) and the Gisborne-based medical cannabis company announced Phase I of the new trial on Tuesday.“Over the past week, the first cohort of marae-based participants engaged in preparatory and experiential sessio...

More Markets

NZ sharemarket ends short week up 0.4%
Markets Market Close

NZ sharemarket ends short week up 0.4%

The S&P/NZX 50 Index closed at 12,902.19, up 57.6 points or 0.45%.

Graham Skellern 07 Feb 2025
Updated: Manawa shares sag with Contact deal odds
Finance

Updated: Manawa shares sag with Contact deal odds

Forsyth Barr analysts said chances are now 50/50. 

Pattrick Smellie 07 Feb 2025
Updated: Fletcher says no change to NZICC date
Markets

Updated: Fletcher says no change to NZICC date

Both SkyCity and Fletcher Building say they are not to blame for the NZICC delay.

Dileepa Fonseka 07 Feb 2025